Last updated: December 11, 2024
Sponsor: Jacques E. Chelly
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Vagal Nerve Stimulator
Placebo Vagal Nerve Stimulator
Clinical Study ID
NCT06648759
STUDY24070152
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Adults (18 and older) undergoing laparoscopic or open colorectal surgery, or anymajor abdominal surgeries at UPMC Shadyside
Development of post-operative ileus
Anticipation of a nasogastric (ng) tube being placed
Exclusion
Exclusion Criteria:
Pregnant subjects
Subjects who are unable to read, write, or speak English fluently
Subjects who have a developmental or neurological disorder and are not cognitivelyable to provide consent
Study Design
Total Participants: 60
Treatment Group(s): 2
Primary Treatment: Vagal Nerve Stimulator
Phase:
Study Start date:
December 04, 2024
Estimated Completion Date:
September 30, 2026
Study Description
Connect with a study center
UPMC Shadyside Hospital
Pittsburgh, Pennsylvania 15232
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.